|
Market Closed -
Japan Exchange
02:30:00 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 6,198.00 JPY | -0.21% |
|
-1.51% | -21.97% |
| Fiscal Period: May | 2017 (JPY) | 2018 (JPY) | 2019 (JPY) | 2020 (JPY) | 2021 (JPY) | 2022 (JPY) | 2023 (JPY) | 2024 (JPY) | 2025 (JPY) | 2026 (JPY) |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 5.29 | 4.8 | 4.39 | 5.04 | 4.72 | |||||
Return on Total Capital | 9.78 | 8.77 | 7.96 | 8.82 | 7.91 | |||||
Return On Equity % | 12.83 | 11.85 | 11.05 | 12.67 | 11.84 | |||||
Return on Common Equity | 12.83 | 11.85 | 11.05 | 12.67 | 11.84 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 20.05 | 20.38 | 19.51 | 21.09 | 20.89 | |||||
SG&A Margin | 14.26 | 14.84 | 14.36 | 15.07 | 14.98 | |||||
EBITDA Margin % | 5.94 | 5.74 | 5.33 | 6.19 | 6.09 | |||||
EBITA Margin % | 3.94 | 3.64 | 3.26 | 3.99 | 3.85 | |||||
EBIT Margin % | 3.94 | 3.64 | 3.26 | 3.99 | 3.85 | |||||
Income From Continuing Operations Margin % | 3.07 | 2.88 | 2.53 | 3.06 | 2.91 | |||||
Net Income Margin % | 3.07 | 2.88 | 2.53 | 3.06 | 2.91 | |||||
Net Avail. For Common Margin % | 3.07 | 2.88 | 2.53 | 3.06 | 2.91 | |||||
Normalized Net Income Margin | 2.72 | 2.5 | 2.22 | 2.67 | 2.54 | |||||
Levered Free Cash Flow Margin | -2.03 | 0.61 | -0.83 | -0.65 | -1.63 | |||||
Unlevered Free Cash Flow Margin | -2.02 | 0.61 | -0.82 | -0.63 | -1.6 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 2.14 | 2.11 | 2.15 | 2.02 | 1.96 | |||||
Fixed Assets Turnover | 3.59 | 3.41 | 3.48 | 3.23 | 3.09 | |||||
Receivables Turnover (Average Receivables) | 5.07K | 2.55K | 1.77K | 1.45K | 1.33K | |||||
Inventory Turnover (Average Inventory) | 9.52 | 9.16 | 9.49 | 8.94 | 9.09 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.71 | 0.71 | 0.72 | 0.75 | 0.77 | |||||
Quick Ratio | 0.28 | 0.29 | 0.3 | 0.31 | 0.34 | |||||
Operating Cash Flow to Current Liabilities | 0.2 | 0.28 | 0.26 | 0.24 | 0.24 | |||||
Days Sales Outstanding (Average Receivables) | 0.07 | 0.14 | 0.21 | 0.25 | 0.27 | |||||
Days Outstanding Inventory (Average Inventory) | 38.35 | 39.84 | 38.56 | 40.82 | 40.15 | |||||
Average Days Payable Outstanding | 81.49 | 82 | 79.55 | 80.94 | 77.64 | |||||
Cash Conversion Cycle (Average Days) | -43.06 | -42.02 | -40.78 | -39.87 | -37.22 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 4.94 | 8.62 | 14.72 | 19.4 | 27.66 | |||||
Total Debt / Total Capital | 4.71 | 7.94 | 12.83 | 16.25 | 21.67 | |||||
LT Debt/Equity | 3.34 | 6.5 | 11.9 | 16.32 | 23.68 | |||||
Long-Term Debt / Total Capital | 3.18 | 5.98 | 10.38 | 13.67 | 18.55 | |||||
Total Liabilities / Total Assets | 47.53 | 49.86 | 51.43 | 50.94 | 52.44 | |||||
EBIT / Interest Expense | 573.02 | 590.76 | 318.2 | 159.07 | 72.9 | |||||
EBITDA / Interest Expense | 863.6 | 931.31 | 519.45 | 246.59 | 115.2 | |||||
(EBITDA - Capex) / Interest Expense | 27.12 | 16.88 | -44.28 | 36.64 | -6.08 | |||||
Total Debt / EBITDA | 0.21 | 0.38 | 0.66 | 0.8 | 1.17 | |||||
Net Debt / EBITDA | -0.62 | -0.58 | -0.35 | -0.11 | 0.26 | |||||
Total Debt / (EBITDA - Capex) | 6.68 | 21.14 | -7.77 | 5.37 | -22.21 | |||||
Net Debt / (EBITDA - Capex) | -19.82 | -32.2 | 4.16 | -0.76 | -4.85 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 3.99 | 9.57 | 16.59 | 4.81 | 8.72 | |||||
Gross Profit, 1 Yr. Growth % | 4.37 | 11.4 | 11.61 | 13.26 | 7.69 | |||||
EBITDA, 1 Yr. Growth % | -4.31 | 5.77 | 8.27 | 21.79 | 6.86 | |||||
EBITA, 1 Yr. Growth % | -10.11 | 1.11 | 4.56 | 28.26 | 4.82 | |||||
EBIT, 1 Yr. Growth % | -10.11 | 1.11 | 4.56 | 28.26 | 4.82 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -14.73 | 2.77 | 2.76 | 26.68 | 3.45 | |||||
Net Income, 1 Yr. Growth % | -14.73 | 2.77 | 2.76 | 26.68 | 3.45 | |||||
Normalized Net Income, 1 Yr. Growth % | -8.3 | 0.68 | 3.67 | 25.83 | 3.37 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -14.73 | 2.77 | 2.71 | 26.65 | 3.45 | |||||
Accounts Receivable, 1 Yr. Growth % | 98 | 128.28 | 40.93 | 19.47 | 16.82 | |||||
Inventory, 1 Yr. Growth % | 9.6 | 16.75 | 11.22 | 7.14 | 7.27 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 15.45 | 15.17 | 14 | 11.94 | 15.03 | |||||
Total Assets, 1 Yr. Growth % | 6.37 | 15.95 | 13.2 | 10.12 | 13.67 | |||||
Tangible Book Value, 1 Yr. Growth % | 11.64 | 10.76 | 9.7 | 11.29 | 10.02 | |||||
Common Equity, 1 Yr. Growth % | 11.68 | 10.79 | 9.65 | 11.24 | 10.19 | |||||
Cash From Operations, 1 Yr. Growth % | 15.49 | 69.08 | 1.36 | -4.91 | 12.05 | |||||
Capital Expenditures, 1 Yr. Growth % | 66.89 | 7.22 | 19.67 | -4.45 | 32.13 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 664.4 | -132.92 | -258.32 | -18.22 | 174.25 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 677.32 | -133.19 | -256.1 | -19.58 | 175.39 | |||||
Dividend Per Share, 1 Yr. Growth % | 14.29 | 25 | 20 | 16.67 | 17.14 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 5.06 | 6.74 | 13.02 | 10.54 | 6.75 | |||||
Gross Profit, 2 Yr. CAGR % | 5.92 | 7.83 | 11.51 | 12.43 | 10.44 | |||||
EBITDA, 2 Yr. CAGR % | 2.6 | 0.6 | 7.01 | 14.83 | 14.08 | |||||
EBITA, 2 Yr. CAGR % | 1.2 | -4.66 | 2.82 | 15.8 | 15.95 | |||||
EBIT, 2 Yr. CAGR % | 1.2 | -4.66 | 2.82 | 15.8 | 15.95 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 3.93 | -6.39 | 2.77 | 14.09 | 14.48 | |||||
Net Income, 2 Yr. CAGR % | 3.93 | -6.39 | 2.77 | 14.09 | 14.48 | |||||
Normalized Net Income, 2 Yr. CAGR % | 2.03 | -3.91 | 2.17 | 14.21 | 14.05 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 3.93 | -6.39 | 2.74 | 14.05 | 14.46 | |||||
Accounts Receivable, 2 Yr. CAGR % | 35.4 | 112.6 | 79.36 | 29.75 | 18.14 | |||||
Inventory, 2 Yr. CAGR % | 11.31 | 13.12 | 13.95 | 9.16 | 7.2 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 10.24 | 15.31 | 14.59 | 12.97 | 13.48 | |||||
Total Assets, 2 Yr. CAGR % | 6.47 | 11.06 | 14.57 | 11.65 | 11.88 | |||||
Tangible Book Value, 2 Yr. CAGR % | 14.33 | 11.2 | 10.23 | 10.49 | 10.65 | |||||
Common Equity, 2 Yr. CAGR % | 14.36 | 11.24 | 10.22 | 10.44 | 10.72 | |||||
Cash From Operations, 2 Yr. CAGR % | -29.87 | 39.74 | 30.91 | -1.82 | 3.22 | |||||
Capital Expenditures, 2 Yr. CAGR % | 29.47 | 33.76 | 13.27 | 6.93 | 12.36 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -32.82 | 58.62 | -27.81 | 13.79 | 49.76 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -32.94 | 60.63 | -28.02 | 12.04 | 48.81 | |||||
Dividend Per Share, 2 Yr. CAGR % | 20.6 | 19.52 | 22.47 | 18.32 | 16.9 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 7.32 | 6.54 | 9.93 | 10.22 | 9.93 | |||||
Gross Profit, 3 Yr. CAGR % | 7.54 | 7.72 | 9.07 | 12.09 | 10.83 | |||||
EBITDA, 3 Yr. CAGR % | 5.97 | 3.65 | 3.1 | 11.73 | 12.11 | |||||
EBITA, 3 Yr. CAGR % | 6.34 | 1.17 | -1.68 | 10.68 | 12.02 | |||||
EBIT, 3 Yr. CAGR % | 6.34 | 1.17 | -1.68 | 10.68 | 12.02 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 6.47 | 3.55 | -3.43 | 10.19 | 10.43 | |||||
Net Income, 3 Yr. CAGR % | 6.47 | 3.55 | -3.43 | 10.19 | 10.43 | |||||
Normalized Net Income, 3 Yr. CAGR % | 6.38 | 1.58 | -1.45 | 9.51 | 10.48 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 6.47 | 3.55 | -3.45 | 10.16 | 10.4 | |||||
Accounts Receivable, 3 Yr. CAGR % | -20.76 | 61.15 | 85.37 | 56.64 | 25.29 | |||||
Inventory, 3 Yr. CAGR % | 7.59 | 13.1 | 12.48 | 11.63 | 8.53 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 9.24 | 11.86 | 14.87 | 13.7 | 13.65 | |||||
Total Assets, 3 Yr. CAGR % | 9.89 | 9.54 | 11.77 | 13.07 | 12.32 | |||||
Tangible Book Value, 3 Yr. CAGR % | 14.69 | 13.13 | 10.7 | 10.58 | 10.33 | |||||
Common Equity, 3 Yr. CAGR % | 14.69 | 13.16 | 10.71 | 10.56 | 10.36 | |||||
Cash From Operations, 3 Yr. CAGR % | -2.17 | -5.96 | 25.56 | 17.68 | 2.6 | |||||
Capital Expenditures, 3 Yr. CAGR % | 14.42 | 21.58 | 28.89 | 7.03 | 14.75 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 72.55 | -47.04 | 58.52 | -24.75 | 52.56 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 71.51 | -46.95 | 59.11 | -25.31 | 51.2 | |||||
Dividend Per Share, 3 Yr. CAGR % | 16.96 | 22.05 | 19.68 | 20.51 | 17.93 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 8.48 | 8.21 | 9.57 | 8.12 | 8.64 | |||||
Gross Profit, 5 Yr. CAGR % | 8.65 | 8.87 | 9.11 | 9.58 | 9.62 | |||||
EBITDA, 5 Yr. CAGR % | 6.39 | 6.52 | 6.39 | 7.99 | 7.36 | |||||
EBITA, 5 Yr. CAGR % | 6.03 | 5.78 | 4.92 | 6.79 | 5.02 | |||||
EBIT, 5 Yr. CAGR % | 6.03 | 5.78 | 4.92 | 6.79 | 5.02 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 4.92 | 6.18 | 4.97 | 7.64 | 3.37 | |||||
Net Income, 5 Yr. CAGR % | 4.92 | 6.18 | 4.97 | 7.64 | 3.37 | |||||
Normalized Net Income, 5 Yr. CAGR % | 5.97 | 5.55 | 4.68 | 6.46 | 4.48 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 4.92 | 6.18 | 4.96 | 7.63 | 3.35 | |||||
Accounts Receivable, 5 Yr. CAGR % | 55.18 | 37.79 | 9.86 | 47.77 | 54.8 | |||||
Inventory, 5 Yr. CAGR % | 10.63 | 9.71 | 10.09 | 11.5 | 10.34 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 10.88 | 11 | 11.35 | 12.3 | 14.31 | |||||
Total Assets, 5 Yr. CAGR % | 9.97 | 10.93 | 11.74 | 10.38 | 11.81 | |||||
Tangible Book Value, 5 Yr. CAGR % | 15.41 | 14.16 | 12.88 | 12.07 | 10.68 | |||||
Common Equity, 5 Yr. CAGR % | 15.41 | 14.15 | 12.88 | 12.06 | 10.71 | |||||
Cash From Operations, 5 Yr. CAGR % | -2.71 | 10.81 | 9.92 | -4.33 | 16.1 | |||||
Capital Expenditures, 5 Yr. CAGR % | 8.7 | 9.63 | 13.96 | 15.5 | 22.01 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 28.02 | 83.68 | 21.77 | -28.09 | 54.96 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 27.62 | 93.68 | 21.19 | -28.46 | 54.91 | |||||
Dividend Per Share, 5 Yr. CAGR % | 14.87 | 17.32 | 19.14 | 20.55 | 18.56 |
- Stock Market
- Stocks
- 3349 Stock
- Financials COSMOS Pharmaceutical Corporation
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















